Comparison of WatchPAT to polysomnography measurement of apnea-hypopnea index and obstructive sleep apnea severity in adolescents with overweight and obesity.
Mia L Dobbin, Angel Bernard, Laura Pyle, Norman Friedman, Melanie G Cree, Stephen M M Hawkins, Stacey L Simon
{"title":"Comparison of WatchPAT to polysomnography measurement of apnea-hypopnea index and obstructive sleep apnea severity in adolescents with overweight and obesity.","authors":"Mia L Dobbin, Angel Bernard, Laura Pyle, Norman Friedman, Melanie G Cree, Stephen M M Hawkins, Stacey L Simon","doi":"10.5664/jcsm.11530","DOIUrl":null,"url":null,"abstract":"<p><strong>Study objectives: </strong>The prevalence of obstructive sleep apnea (OSA) increases dramatically in adolescents with overweight or obesity. The gold standard for diagnosis of OSA is in-laboratory polysomnography (PSG). However, access to PSG can be challenging, necessitating development of alternative devices. This study aimed to compare the accuracy of WatchPAT, a device that indirectly detects apnea and hypopnea events through peripheral arterial tonometry, to PSG in adolescents with overweight and obesity.</p><p><strong>Methods: </strong>38 participants (15.5±1.6 years; 76% female; 40% Hispanic/Latino; BMI 97.7±2.0 percentile) were analyzed. Correlation, agreement, sensitivity, specificity, and concordance between WatchPAT with PSG-derived measures of apnea-hypopnea index (AHI) and OSA severity were conducted. A subset (n=21) underwent subjective assessment of nasal flow sensor reliability and video characteristics to evaluate possible underestimation of PSG-assessed AHI.</p><p><strong>Results: </strong>Mean bias between WatchPAT- and PSG-derived AHI was 16.9±13.4 events/hour (95% CI 12.5-21.3). WatchPAT overestimated OSA severity compared to PSG in 89% of participants. Sensitivity was 62-100% and specificity was 5.5-32% across all OSA severity levels. Of the subset with subjective assessment of PSG data, 38% had nasal flow sensor reliability <75%, 14% had underestimated AHI, and 28% had probably underestimated AHI. However, these characteristics did not fully explain the discrepancy between WatchPAT and PSG measurements.</p><p><strong>Conclusions: </strong>The WatchPAT device showed a significant discrepancy compared to the gold-standard PSG in measurement of AHI and accuracy of OSA severity in adolescents with overweight or obesity. Future research is needed to understand pathophysiological differences to enhance assessment of OSA in this high-risk population.</p>","PeriodicalId":50233,"journal":{"name":"Journal of Clinical Sleep Medicine","volume":" ","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Sleep Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5664/jcsm.11530","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Study objectives: The prevalence of obstructive sleep apnea (OSA) increases dramatically in adolescents with overweight or obesity. The gold standard for diagnosis of OSA is in-laboratory polysomnography (PSG). However, access to PSG can be challenging, necessitating development of alternative devices. This study aimed to compare the accuracy of WatchPAT, a device that indirectly detects apnea and hypopnea events through peripheral arterial tonometry, to PSG in adolescents with overweight and obesity.
Methods: 38 participants (15.5±1.6 years; 76% female; 40% Hispanic/Latino; BMI 97.7±2.0 percentile) were analyzed. Correlation, agreement, sensitivity, specificity, and concordance between WatchPAT with PSG-derived measures of apnea-hypopnea index (AHI) and OSA severity were conducted. A subset (n=21) underwent subjective assessment of nasal flow sensor reliability and video characteristics to evaluate possible underestimation of PSG-assessed AHI.
Results: Mean bias between WatchPAT- and PSG-derived AHI was 16.9±13.4 events/hour (95% CI 12.5-21.3). WatchPAT overestimated OSA severity compared to PSG in 89% of participants. Sensitivity was 62-100% and specificity was 5.5-32% across all OSA severity levels. Of the subset with subjective assessment of PSG data, 38% had nasal flow sensor reliability <75%, 14% had underestimated AHI, and 28% had probably underestimated AHI. However, these characteristics did not fully explain the discrepancy between WatchPAT and PSG measurements.
Conclusions: The WatchPAT device showed a significant discrepancy compared to the gold-standard PSG in measurement of AHI and accuracy of OSA severity in adolescents with overweight or obesity. Future research is needed to understand pathophysiological differences to enhance assessment of OSA in this high-risk population.
研究目的:阻塞性睡眠呼吸暂停(OSA)的患病率在超重或肥胖的青少年中急剧增加。诊断OSA的金标准是实验室多导睡眠图(PSG)。然而,获得PSG可能具有挑战性,需要开发替代设备。这项研究旨在比较WatchPAT(一种通过外周动脉压测间接检测呼吸暂停和低通气事件的设备)与超重和肥胖青少年PSG的准确性。方法:38例(15.5±1.6岁;76%的女性;拉丁美洲裔40%;BMI(97.7±2.0百分位数)。观察WatchPAT与psg衍生的呼吸暂停低通气指数(AHI)和OSA严重程度之间的相关性、一致性、敏感性、特异性和一致性。一个子集(n=21)接受了鼻流量传感器可靠性和视频特征的主观评估,以评估psg评估的AHI可能被低估的情况。结果:WatchPAT和psg衍生AHI的平均偏差为16.9±13.4事件/小时(95% CI 12.5-21.3)。与PSG相比,WatchPAT高估了89%的参与者的OSA严重程度。所有OSA严重程度的敏感性为62-100%,特异性为5.5-32%。结论:与金标准PSG相比,WatchPAT设备在测量超重或肥胖青少年的AHI和OSA严重程度的准确性方面存在显著差异。未来的研究需要了解这些高危人群的病理生理差异,以加强对OSA的评估。
期刊介绍:
Journal of Clinical Sleep Medicine focuses on clinical sleep medicine. Its emphasis is publication of papers with direct applicability and/or relevance to the clinical practice of sleep medicine. This includes clinical trials, clinical reviews, clinical commentary and debate, medical economic/practice perspectives, case series and novel/interesting case reports. In addition, the journal will publish proceedings from conferences, workshops and symposia sponsored by the American Academy of Sleep Medicine or other organizations related to improving the practice of sleep medicine.